AMEREN CORP

For the period ended Sep 30, 2026. Filed Nov 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 6, 2026

AEE$114.02+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheet

CONSOLIDATED BALANCE SHEET

	September 30,2026	December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents	$26	$6
Accounts receivable – trade (less allowance for doubtful accounts of $19 and $17, respectively)	409	284
Accounts receivable – affiliates	14	15
Unbilled revenue	297	193
Miscellaneous accounts receivable	68	15
Inventories	549	492
Current regulatory assets	135	181
Other current assets	190	119
Total current assets	1,688	1,305
Property, Plant, and Equipment, Net	22,709	20,604
Investments and Other Assets:
Nuclear decommissioning trust fund	1,638	1,526
Regulatory assets (includes $426 and $443 related to VIEs, respectively)	1,610	1,450
Pension and other postretirement benefits	279	271
Other assets	352	244
Total investments and other assets	3,879	3,491
TOTAL ASSETS	$28,276	$25,400
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Current maturities of long-term debt (includes $24 and $23 related to VIEs, respectively)	$424	$23
Short-term debt	100	471
Accounts and wages payable	485	696
Accounts payable – affiliates	110	61
Taxes accrued	212	34
Interest accrued	95	99
Other current liabilities	193	178
Total current liabilities	1,619	1,562
Long-term Debt, Net (includes $414 and $426 related to VIEs, respectively)	9,072	8,120
Long-term Debt, Net - Related Parties	107	87
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and tax credits, net	2,935	2,702
Regulatory liabilities	3,414	3,324
Asset retirement obligations	858	844
Other deferred credits and liabilities	329	184
Total deferred credits and other liabilities	7,536	7,054
Commitments and Contingencies (Notes 2, 8, 9, and 10)
Shareholders’ Equity:
Common stock, $5 par value, 150.0 shares authorized – 102.1 shares outstanding	511	511
Other paid-in capital, principally premium on common stock	3,779	3,229
Preferred stock	80	80
Retained earnings	5,572	4,757
Total shareholders’ equity	9,942	8,577
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$28,276	$25,400

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.